Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Payables (2016 - 2025)

Nutex Health's Payables history spans 16 years, with the latest figure at $45.9 million for Q4 2025.

  • For Q4 2025, Payables rose 377.04% year-over-year to $45.9 million; the TTM value through Dec 2025 reached $45.9 million, up 377.04%, while the annual FY2025 figure was $45.9 million, 377.04% up from the prior year.
  • Payables for Q4 2025 was $45.9 million at Nutex Health, up from $45.5 million in the prior quarter.
  • Across five years, Payables topped out at $45.9 million in Q4 2025 and bottomed at $700000.0 in Q3 2023.
  • The 5-year median for Payables is $4.5 million (2021), against an average of $11.4 million.
  • The largest annual shift saw Payables crashed 80.63% in 2023 before it skyrocketed 1883.6% in 2025.
  • A 5-year view of Payables shows it stood at $2.7 million in 2021, then plummeted by 66.69% to $900000.0 in 2022, then changed by 0.0% to $900000.0 in 2023, then surged by 968.22% to $9.6 million in 2024, then skyrocketed by 377.04% to $45.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Payables are $45.9 million (Q4 2025), $45.5 million (Q3 2025), and $28.1 million (Q2 2025).